gc012f
gracell biotechnologies
['hodgkin', 'gc012f ', 'lymphoma', '$grcl', 'gracell']
$grcl - gracell biotechnologies presents longer-term results for fastcar-t gc012f in b-cell non-hodgkin's lymphoma at eha2023, highlighting 100% overall response rate 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.